T-cell Immunoglobulin and Mucin-domain containing-1
TIMD4proteinTIM-1 modulates immune tolerance and inflammatory responses in acute coronary syndrome pathogenesis.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleImmune checkpoint regulator; role in plaque inflammation and ACS outcomes.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000145850
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(2)
- Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function.Clinical kidney journal · 2024 · PMID 38524235 · doi
- Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction.Scientific reports · 2022 · PMID 35595781 · doi